Merriman Wealth Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$449K Buy
888
+178
+25% +$101K 0.02% 138
2024
Q3
$415K Buy
710
+5
+0.7% +$2.83K 0.02% 154
2024
Q2
$359K Sell
705
-41
-5% -$20.1K 0.02% 158
2024
Q1
$369K Sell
746
-418
-36% -$213K 0.02% 153
2023
Q4
$613K Buy
1,164
+501
+76% +$267K 0.03% 116
2023
Q3
$334K Buy
663
+21
+3% +$10.3K 0.02% 141
2023
Q2
$309K Buy
642
+19
+3% +$9.29K 0.02% 173
2023
Q1
$294K Sell
623
-52
-8% -$25.1K 0.02% 163
2022
Q4
$358K Buy
+675
New +$358K 0.02% 158
2019
Q1
Sell
-1,168
Closed -$280K 228
2018
Q4
$280K Buy
1,168
+77
+7% +$20.3K 0.06% 129
2018
Q3
$290K Sell
1,091
-426
-28% -$111K 0.06% 144
2018
Q2
$372K Buy
1,517
+201
+15% +$48.3K 0.08% 126
2018
Q1
$282K Buy
1,316
+15
+1% +$3.43K 0.07% 152
2017
Q4
$287K Buy
+1,301
New +$276K 0.07% 144

Other funds holding UNH

Merriman Wealth Management's UNH Position: Q4 2024 in Review

Merriman Wealth Management increased its UnitedHealth (UNH) stake by 25% in Q4 2024, buying an estimated $101K and bringing the position to 888 shares worth $449K. The position accounts for 0.02% of the portfolio, ranked #138.

Merriman Wealth Management first reported a position in UNH in Q4 2017 and has held it in 14 quarters since. The position peaked at $613K in Q4 2023. 3,681 funds tracked by Wall St. Rank hold UNH as of Q4 2024.

  • Merriman Wealth Management held 888 shares of UnitedHealth worth $449K as of Q4 2024.
  • Merriman Wealth Management bought 178 UnitedHealth shares in Q4 2024, an estimated $101K.
  • UnitedHealth made up 0.02% of Merriman Wealth Management's portfolio in Q4 2024, its #138 holding.
  • Merriman Wealth Management first reported a position in UnitedHealth in Q4 2017 and has held it in 14 quarters since.
  • Merriman Wealth Management's UnitedHealth position peaked at $613K in Q4 2023.
  • 3,681 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2024.

Based on Merriman Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.